Analyst Ratings for Regeneron Pharma (REGN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/21/2011 | BofA/Merrill Lynch | N/A | Upgrade | Neutral (N/A) |
N/A (N/A) |
52.62 (54.42) |
3.42% | Details |
| 11/10/2011 | Roth Capital | N/A | Upgrade | Buy (N/A) |
75.00 (N/A) |
54.06 (54.42) |
0.67% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
